HM
Heather Ann McSharry
Director

Heather Ann McSharry insider trades: Jazz Pharmaceuticals (JAZZ) stock sales

Director, Jazz Pharmaceuticals Last trade May 22, 2026 20 Form 4 filings
$1.1M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2015
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Heather reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 22, 2026JAZZ↓ Sell$482K
Nov 20, 2025JAZZ↓ Sell$607K
Aug 14, 2023JAZZ↓ Sell$186K
Aug 8, 2022JAZZ↓ Sell$1.0M
Aug 6, 2021JAZZ↓ Sell$209K
Aug 7, 2020JAZZ↓ Sell$127K
Aug 9, 2019JAZZ↓ Sell$107K
Aug 10, 2018JAZZ↓ Sell$126K
Aug 11, 2017JAZZ↓ Sell$102K
Aug 15, 2016JAZZ↓ Sell$93K
May 16, 2016JAZZ↓ Sell$101K
Aug 10, 2015JAZZ↓ Sell$156K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other JAZZ insiders

Open-market trades in the last 12 months

About Heather Ann McSharry's insider trades

Heather Ann McSharry is a director at Jazz Pharmaceuticals (JAZZ). Since Aug 10, 2015, Heather has reported no open-market purchases and 12 sales worth $3.3M on SEC Form 4. In the last 12 months: 2 sales ($1.1M).

Their filings also include grants and awards (14 filings), shares withheld for taxes (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAZZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.